
Technology frontiers &
clinical practice
Latest updates from Shanghai HONGYU Medical's R&D center, partner hospitals, and industry conferences.

Chuan Animal Hospital from Taiwan Completed Their V-Clamp Surgery Training!
Overview Chuan Animal Hospital team from Taiwan led by Dr. Ta-Li Lu visited Shanghai Hongyu Medical and completed their V-Clamp surgery training successfully.

Four Challenging Canine Mitral Valve Repair Surgeries Completed in Six Weeks by Korean V-Clamp Team
Overview Recently, our Korean V-Clamp medical team has completed a series of highly challenging mitral valve repair surgeries on pet dogs, which is a record for both KAMC and Hongyu.

V-Clamp is Starting to Make Its Mark in Australia’s Three Largest Cities
Overview HongYu Medical welcomed the Advanced Vetcare team from Melbourne, Australia this mid-May. Advanced Vetcare Australia team turned to be the third Australian vet team that completed the V-Clamp surgery.

A New Ray of Hope for MR Patients in India Has Been Introduced by Doctor Bhanu
Overview 您的浏览器不支持 video 标签。 The V-Clamp surgery has become a new ray of hope for vets, patients and dog owners in India to treat canine mitral valve disease with the efforts of doctor Bhanu Dev Sharma and his team from MaxPetZ (a India's leading chain of multi-specialty veteri...

Th First Case in Florida: V-Clamp Becomes A Life-Saver for Pekingese Dog Vito
Overview 您的浏览器不支持 video 标签。 The first V-Clamp minimally invasive mitral valve repair commercial case in Florida was completed successfully by medical team from Sawgrass Veterinary Cardiology and ACCESS Palm Beach with the technical assistance from HongYu Medical at the end of...

V-Clamp Training Review of Malaysian Shinzo Cardiology Team
Overview On 10th May, doctor Leong and his team from Malaysia Shinzo Cardiology Clinic completed their V-Clamp training successfully at Shanghia HongYu Medical!
Past highlights
Chuan Animal Hospital from Taiwan Completed Their V-Clamp Surgery Training!
Partnership
Collaboration opportunities welcome
For content syndication, co-publishing, or clinical and market collaboration, we welcome further discussion.
Partnership inquiry